Namita Sood

Title(s)Professor, MED: Int Med Pulmonary, Critical Care, and Sleep Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Research 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Smoking-Related Clinical and Molecular Abnormalities in Idiopathic Pulmonary Fibrosis-Associated Pulmonary Hypertension. Pulm Circ. 2026 Sep; 16(3):e70349. Zhyvylo I, Sood N, Pugashetti JV, Linderholm AL, Hsu SW, Oldham J, Chen CH, Goncharova EA. PMID: 42454257; PMCID: PMC13366116.
      View in: PubMed   Mentions:
    2. Managing a Critically Ill Patient With Pulmonary Arterial Hypertension. Chest. 2026 May 22. Sulica R, De Marco T, Elwing JM, Bartolome S, Sood N. PMID: 42176848.
      View in: PubMed   Mentions:    Fields:    
    3. Prognostic Impact of Quantitative CT Disease Extent and Pattern in Fibrotic Hypersensitivity Pneumonitis. Ann Am Thorac Soc. 2026 May 13. Fernández Pérez ER, Humphries SM, Lynch DA, Moua T, Chaudhary S, Adams TN, Adegunsoye A, Scholand MB, Sood N, Vestal B. PMID: 42127984.
      View in: PubMed   Mentions:    Fields:    
    4. Validity and Prognostic Value of the UCSD Dyspnea Questionnaire in Fibrotic Hypersensitivity Pneumonitis: A Multicenter Prospective Study. Ann Am Thorac Soc. 2026 May 13. Swigris JJ, Moua T, Chaudhary S, Adams TN, Adegunsoye A, Scholand MB, Sood N, Vestal B, Fernández Pérez ER. PMID: 42127979.
      View in: PubMed   Mentions:    Fields:    
    5. Real-World Outcomes of Inhaled Treprostinil in Pulmonary Hypertension Related to Interstitial Lung Disease: A Multicenter, Retrospective Analysis. J Cardiovasc Dev Dis. 2026 Mar 10; 13(3). Kyle AR, Jose A, Catherman K, Elwing J, Sulica R, Zavorsky GS, Sood N. PMID: 41892717; PMCID: PMC13027211.
      View in: PubMed   Mentions:
    6. Efficacy and Safety of Oral Treprostinil in Patients with Pulmonary Arterial Hypertension on Background Monotherapy or Dual Therapy. Adv Ther. 2026 Mar; 43(3):1308-1326. Lachant D, Raina A, Krishnan M, Sood N, Balasubramanian V, Barbera JA, Kiely DG, Lee D, Wu B, Hwang S, Seaman S, Broderick M, Elwing J. PMID: 41627369; PMCID: PMC12999644.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Methamphetamine-Associated Pulmonary Arterial Hypertension: Impact, Mechanisms, and a Framework for Management. Pulm Circ. 2026 Jan; 16(1):e70242. Sood N, Weerasekare J, Zhyvylo I, Goncharova EA, De Marco T. PMID: 41567751; PMCID: PMC12817132.
      View in: PubMed   Mentions:
    8. Baseline and Change in Peripheral Blood Transcriptome Enhance Outcome Prediction in Fibrotic Hypersensitivity Pneumonitis: A Prospective Multicenter Cohort Study. medRxiv. 2025 Nov 15. Fernández Pérez ER, Leach SM, Humphries SM, Lynch DA, Moua T, Chaudhary S, Adams TN, Adegunsoye A, Scholand MB, Sood N, Vestal B. PMID: 41292621; PMCID: PMC12642745.
      View in: PubMed   Mentions:
    9. American Lung Association Pulmonary Hypertension Roundtable: Executive Summary. Pulm Circ. 2025 Oct; 15(4):e70200. Kolaitis NA, Sahay S, Rosenzweig EB, Brown D, Hemnes A, Joseloff E, Meyer J, Pescatore KA, Rizzo A, Sood N, Stewart B, McLaughlin V, Williamson T, Klinger JR. PMID: 41245392; PMCID: PMC12617243.
      View in: PubMed   Mentions: 1  
    10. Prognostic Impact of Quantitative CT Disease Extent and Pattern in Hypersensitivity Pneumonitis. medRxiv. 2025 Oct 14. Fernández Pérez ER, Humphries SM, Lynch DA, Moua T, Chaudhary S, Adams TN, Adegunsoye A, Scholand MB, Sood N, Vestal B. PMID: 41282708; PMCID: PMC12633107.
      View in: PubMed   Mentions:
    11. Psychometric Properties and Prognostic Value of the UCSD Shortness of Breath Questionnaire in Hypersensitivity Pneumonitis: A Prospective Cohort Study. medRxiv. 2025 Sep 27. Swigris JJ, Moua T, Chaudhary S, Adams TN, Adegunsoye A, Scholand MB, Sood N, Vestal B, Fernández Pérez ER. PMID: 41040710; PMCID: PMC12486042.
      View in: PubMed   Mentions:
    12. Pulmonary Hypertension Associated With Interstitial Lung Diseases. Chest. 2026 Jan; 169(1):220-229. Jose A, Sood N, Elwing JM, Akkanti B, Bajwa A, Bernardo R, Estrada RA, Sharma M, Soto FJ, Tonelli AR, Verma D, Vintch J, Sahay S, Shlobin OA, Pulmonary Vascular Disease (PVD) Section. PMID: 40939937; PMCID: PMC12895325.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study. Adv Ther. 2025 Oct; 42(10):5104-5123. Sitbon O, Sahay S, Escribano Subías P, Zolty RL, Kingrey JF, Ryan JJ, Sobol I, Sood N, Benza RL, Channick RN, Chin KM, Frantz RP, Ghofrani HA, Hemnes AR, McLaughlin VV, Vachiéry JL, Zamanian RT, Ter Veer A, Roscigno RF, Mottola D, Parsley E, Aranda R, Zisman LS, Howard LS, TORREY Study Investigators. PMID: 40788460; PMCID: PMC12474731.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    14. Safety and pharmacokinetics of ralinepag, a novel oral prostacyclin receptor agonist. JHLT Open. 2025 Aug; 9:100270. Ataya A, Coons JC, Patzlaff N, Broderick M, Seaman S, Sood N, Patricia George M, Chakinala MM. PMID: 40485996; PMCID: PMC12143825.
      View in: PubMed   Mentions: 2  
    15. Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension. Adv Ther. 2024 03; 41(3):1062-1074. Barberà J, Jansa P, Klings E, Ristic A, Keogh A, Solum D, Rao Y, Grover R, Saib I, Sood N. PMID: 38198043; PMCID: PMC10879237.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    16. Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat. Pulm Circ. 2022 Apr; 12(2):e12055. Rahaghi FF, Balasubramanian VP, Bourge RC, Burger CD, Chakinala MM, Eggert MS, Elwing JM, Feldman J, King C, Klinger JR, Mathai SC, McConnell JW, Palevsky HI, Restrepo-Jaramillo R, Safdar Z, Sager JS, Sood N, Sulica R, White RJ, Hill NS. PMID: 35514769; PMCID: PMC9063960.
      View in: PubMed   Mentions: 7  
    17. Lipoid Pneumonia: Fat Chance of Making the Diagnosis? Chest. 2021 08; 160(2):407-408. Sood N, Murin S. PMID: 34366027.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil. Pulm Pharmacol Ther. 2021 02; 66:101979. Rahaghi FF, Allen RP, Balasubramanian VP, Chakinala MM, Elwing JM, Feldman J, Leary PJ, Rischard F, Safdar Z, Sood N, Oudiz RJ. PMID: 33259923.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. A Previously Healthy Policeman with Persistent Fevers, Pulmonary Infiltrates, and Multiorgan Failure. Ann Am Thorac Soc. 2020 09; 17(9):1154-1157. Salahuddin M, Mathew R, Zhao B, Sood N. PMID: 32870061.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies). Pulm Circ. 2020 Jul-Sep; 10(3):2045894020942121. Ghofrani HA, Grünig E, Jansa P, Langleben D, Rosenkranz S, Preston IR, Rahaghi F, Sood N, Busse D, Meier C, Humbert M. PMID: 32728421; PMCID: PMC7366414.
      View in: PubMed   Mentions: 3  
    21. Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial. J Heart Lung Transplant. 2020 05; 39(5):464-472. Preston IR, Burger CD, Bartolome S, Safdar Z, Krowka M, Sood N, Ford HJ, Battarjee WF, Chakinala MM, Gomberg-Maitland M, Hill NS. PMID: 32008947.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    22. Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial. Eur Respir J. 2019 10; 54(4). Torres F, Farber H, Ristic A, McLaughlin V, Adams J, Zhang J, Klassen P, Shanahan W, Grundy J, Hoffmann I, Cabell C, Escribano Subías P, Sood N, Keogh A, D'Souza G, Rubin L. PMID: 31391223.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    23. Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study. Pulm Circ. 2019 Jan-Mar; 9(1):2045894018823715. Sood N, Aranda A, Platt D, LaRose A, Kleinjung F, O'Brien G. PMID: 30574833; PMCID: PMC6381432.
      View in: PubMed   Mentions: 4  
    24. Mortality in Patients With Pulmonary Arterial Hypertension Treated With Continuous Prostanoids. Chest. 2018 09; 154(3):532-540. Bartolome SD, Sood N, Shah TG, Styrvoky K, Torres F, Chin KM. PMID: 29679599.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    25. Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document. Pulm Circ. 2017 Jul-Sep; 7(3):702-711. Rahaghi FF, Alnuaimat HM, Awdish RLA, Balasubramanian VP, Bourge RC, Burger CD, Butler J, Cauthen CG, Chakinala MM, deBoisblanc BP, Eggert MS, Engel P, Feldman J, McConnell JW, Park M, Sager JS, Sood N, Palevsky HI. PMID: 28671484; PMCID: PMC5841904.
      View in: PubMed   Mentions: 9  
    26. Individual dose adjustment of riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir Med. 2017 08; 129:124-129. Hill NS, Rahaghi FF, Sood N, Frey R, Ghofrani HA. PMID: 28732819.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    27. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016 Feb; 149(2):315-352. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. PMID: 26867832.
      View in: PubMed   Mentions: 1666     Fields:    Translation:Humans
    28. Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. Chest. 2014 Aug; 146(2):449-475. Taichman DB, Ornelas J, Chung L, Klinger JR, Lewis S, Mandel J, Palevsky HI, Rich S, Sood N, Rosenzweig EB, Trow TK, Yung R, Elliott CG, Badesch DB. PMID: 24937180; PMCID: PMC4137591.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    29. Managing an acutely ill patient with pulmonary arterial hypertension. Expert Rev Respir Med. 2013 Feb; 7(1):77-83. Sood N. PMID: 23362817.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. A 42-year-old man with fever, shock, and rash. Chest. 2010 Nov; 138(5):1256-9. Rahmanian SD, Molenda M, Fox C, Zirwas M, Sood N. PMID: 21051404.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Community-acquired methicillin-resistant Staphylococcus aureus epidural abscess with bacteremia and multiple lung abscesses: case report. Am J Crit Care. 2009 Jan; 18(1):88, 86-7. Bruns AS, Sood N. PMID: 19116411.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    32. A 77-year-old farmer with respiratory failure and thrombocytopenia. Chest. 2006 May; 129(5):1378-81. Valdivia-Arenas MA, Sood N. PMID: 16685032.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    33. Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects. Am J Respir Crit Care Med. 2003 Jan 15; 167(2):158-63. Sood N, Bennett WD, Zeman K, Brown J, Foy C, Boucher RC, Knowles MR. PMID: 12411282.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    Namita's Networks
    Concepts (101)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (10)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California